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PER-1 extended-spectrum -lactamase-producing Gram-negative bacilli are resistant to oxyimino-cephalo-
sporins. However, the blaPER-1 gene has never been reported in Klebsiella pneumoniae. Here, we studied
interspecies dissemination of the blaPER-1 gene by horizontal transfer of Tn1213 among Acinetobacter bauman-
nii, Pseudomonas aeruginosa, and K. pneumoniae. In a K. pneumoniae clinical isolate, the blaPER-1 gene was
located on a 150-kbp incompatibility group A/C plasmid.
The bla gene encoding PER-1 extended-spectrum -lacta-
mase (ESBL), which can hydrolyze penicillins, oxyimino-ceph-
alosporins, and aztreonam but not oxacillins, cephamycins, and
carbapenems, was first detected on a plasmid of Pseudomonas
aeruginosa RNL-1 from France in 1991 (9). The widespread
dissemination of the gene in Acinetobacter spp. (46%) and P.
aeruginosa (11%) in Turkey was reported in 1997, and further
dissemination of the gene into European countries, such as
Italy, Belgium, and Russia, has been noted (5, 7, 8, 10, 19). In
2003, a high prevalence of the blaPER-1 gene in Acinetobacter
spp. (55%) isolated from patients hospitalized in an intensive
care unit (ICU) in Korea was reported, and further dissemi-
nation of the gene into Asian countries, such as China, Japan,
and India, has also been detected (6, 20–22). The blaPER-1 gene
has been detected mainly in glucose-nonfermenting Gram-
negative bacilli, such as P. aeruginosa, Acinetobacter spp., and
Alcaligenes faecalis; however, it has also recently been found in
Enterobacteriaceae, such as Providencia spp., Proteus spp., Sal-
monella spp., and Aeromonas media (2, 9, 11–13, 18, 19).
A 68-year-old female who presented with dyspnea and facial
paralysis after a bamboo stick injury on the left leg was admit-
ted to the ICU of a tertiary-care hospital in Gwangju, Republic
of Korea, on 16 May 2006. She showed symptoms of pneumo-
nia, and Acinetobacter baumannii and Staphylococcus aureus
were repeatedly recovered from sputum specimens. Ceftazi-
dime and vancomycin were administered for the treatment of
pneumonia; however, she expired on 16 June due to the oc-
currence of disseminated intravascular coagulation. Klebsiella
pneumoniae CS1711 isolate was recovered from the blood
specimen obtained 1 day before she died.
Strain CS1711 exhibited resistance to ampicillin, piperacil-
lin, ceftazidime, cefotaxime, cefepime, gentamicin, amikacin,
and tetracycline and was susceptible to cefoxitin and imipenem
by a disk diffusion assay (5). Synergy was observed between the
amoxicillin-clavulanic acid (20 and 10 g) disk and the cef-
tazidime (30 g), cefotaxime (30 g), cefepime (30 g), and
aztreonam (30 g) disks (Becton Dickinson, Sparks, MD) in
double-disk synergy tests, indicating the production of ESBL
(17). Agar dilution MIC testing on Mueller-Hinton agar (Difco
Laboratories, Detroit, MI) with an inoculum of 104 CFU per
spot confirmed MICs of ceftazidime (MIC, 16 g/ml), cefo-
taxime (MIC, 64 g/ml), cefepime (MIC, 64 g/ml), aztreo-
nam (MIC, 16 g/ml), cefoxitin (MIC, 4 g/ml), amikacin
(MIC, 256 g/ml), and ciprofloxacin (MIC, 1 g/ml) for
strain CS1711 (17). Clavulanic acid (Sigma, St. Louis, MO) at
a fixed concentration of 4 g/ml lowered the MICs of ceftazi-
dime, cefotaxime, and cefepime to 1 g/ml, 0.12 g/ml, and 0.5
g/ml, respectively (Table 1).
The strain transferred an 150-kbp plasmid (pCS1711) to
the Escherichia coli J53 azideR recipient in mating experiments
in which transconjugants were selected on MacConkey agar
(Difco Laboratories, Detroit, MI) plates supplemented with
cefotaxime (2 g/ml) and sodium azide (100 g/ml) (3). MICs
of ceftazidime, cefotaxime, cefepime, amikacin, and ciprofloxacin
for the transconjugant (trcCS1711) were 4 g/ml, 32 g/ml, 8
g/ml, 0.25 g/ml, and 0.025 g/ml, respectively (Table 1).
PCR and sequencing experiments for the detection of genes
encoding TEM-, SHV-, CTX-M-, GES-, VEB-, and PER-type
ESBLs were performed as described previously (1) (Table 2).
Strain CS1711 carried two -lactamase genes, blaPER-1 and
blaCTX-M-9. The location of antimicrobial resistance genes was
identified by hybridization of I-CeuI-digested genomic DNA
or S1 nuclease-treated linearized plasmids with probes specific
for the -lactamase genes, various replicons of plasmids, and
16S rRNA genes as described previously (16). Clinical isolates
of P. aeruginosa (n 8) and A. baumannii (n 14), which were
recovered from clinical samples of patients hospitalized at the
same hospital during May and June 2006, carrying the blaPER-1
gene were included in this study for comparison. The blaPER-1
and the blaCTX-M-9 genes in K. pneumoniae strain CS1711
were located on the 150-kbp IncA/C plasmid (pCS1711 in
transconjugant E. coli trcCS1711). However, the probe specific
for the blaPER-1 gene did not hybridize with any plasmids in 8
P. aeruginosa isolates and 14 A. baumannii isolates. The probe
hybridized with I-CeuI macrorestriction fragments of 500
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kbp and 800 kbp in P. aeruginosa and A. baumannii isolates,
respectively. The probe specific for 16S rRNA genes also hy-
bridized with the I-CeuI macrorestriction fragments, indicating
chromosomal location of the blaPER-1 gene in those P. aerugi-
nosa and A. baumannii isolates.
To investigate genetic environments surrounding the
blaPER-1 gene, sequencing experiments of several overlapping
PCR fragments obtained from whole DNA of the K. pneu-
moniae, A. baumannii, and P. aeruginosa isolates with primers
corresponding to internal region of Tn1213 were performed
as previously described (15). Identically to the results for the
blaPER-1 gene located on the chromosome in P. aeruginosa
RNL-1 (GenBank accession no. AY779042), ISPa12 and
ISPa13 elements were present upstream and downstream of
the blaPER-1 gene, respectively, in all the isolates studied. The
blaPER-1 gene located on a plasmid in two Salmonella enterica
serovar Typhimurium isolates and in strain A. baumannii C.A.
has been reported to be preceded by ISPa12 but not followed
by ISPa13, while the blaPER-1 gene located on the plasmid
pCS1711 was surrounded by both ISPa12 and ISPa13 elements
(4, 14, 15) (Fig. 1). Our results suggest that the blaPER-1 gene
in K. pneumoniae strain CS1711 might be mobilized from
blaPER-1 gene-carrying A. baumannii or P. aeruginosa, since the
genetic environments of the gene in those strains were iden-
tical.
This report shows further dissemination of the blaPER-1 gene
into Enterobacteriaceae and is the first report of K. pneumoniae
carrying the blaPER-1 gene.
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FIG. 1. Genetic environment of the blaPER-1 gene in K. pneumonia
CS1711. Numbered arrows indicate positions and directions of the
primers used in this study as listed in Table 2.
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